Athena M. Countouriotis
Overview
Athena M. Countouriotis received an average of $2M in total compensation, including $369K in salary, at Halozyme Therapeutics from 2015 to 2017.
Source: SEC filings on March 22, 2018 and March 24, 2017.
Related executives
We found 21 more executives who work or worked at Halozyme Therapeutics.
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Michael LaBarre
Halozyme Therapeutics
Senior Vice President, Chief Technical Officer
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Laurie Stelzer
Halozyme Therapeutics
Chief Financial Officer
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
Harry Leonhardt
Halozyme Therapeutics